Advertisements



Mylan to have only a "minor" delay to generic Advair approval, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Even minor delays can hurt Mylan"s generic Advair opportunity, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Mylan (MYL) to Get CRL Again for Generic Advair from FDA

Mylan (MYL) suffers another setback with its ANDA for Advair as the FDA refuses to approve the same, due to minor deficiencies. Shares of Myla.....»»

Category: smallbizSource: nytJun 14th, 2018

Technical Take: Mylan falls after FDA says generic Advair has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Advair generic delay negative news for Mylan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Morgan Stanley says generic Advair delay a small negative for Mylan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan to recover from "modest" generic Advair delay, says Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Mylan falls 4.5% after FDA says generic Advair Diskus has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

FDA says Mylan"s generic Advair Diskus has minor deficiencies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis

With Mylan"s Neulasta Biosimilar Approval, Focus Moves To Advair And Restasis.....»»

Category: topSource: seekingalphaJun 13th, 2018

Biocon 483 letter won"t delay approval of Mylan"s Neulasta, says Bernstein

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 18th, 2018

Amneal Pharmaceuticals receives FDA approval for generic version of BiCNU

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 19th, 2018

Amneal Pharma receives FDA approval for generic version of Isuprel Injection

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 19th, 2018

Mylan announces U.S. launch of generic Depo-Provera

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Corcept slides after Teva gets tentative approval for generic version of Korlym

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Drug Companies To Disclose Pricing Information In Ads

When anger over EpiPen pricing erupted in 2016, generic drugmaker Mylan NV (NASDAQ: MYL) was villainized.  The price of the autoinjector used for severe allergic reactions was hiked by about 500 percent between 2007 and 2016.  read more.....»»

Category: blogSource: benzingaOct 15th, 2018

The9 obtains approval to transfer its listing venue to Nasdaq Capital Market

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Morgan Stanley downgrades Mylan to Equal Weight on generic, Epipen uncertainty

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Wells cuts Mallinckrodt target to $24 after confirming Praxair generic approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

Lannett hires advisers to explore debt and capital structure options

Generic drug maker Lannett Co. Inc. said Monday it has hired advisers to explore debt and capital structure options, as it works to combat the effect of the loss of a key distribution agreement. The company said in August that .....»»

Category: topSource: marketwatchOct 8th, 2018

Approval of Noxivent has mitigating factors for Mallinckrodt, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 3rd, 2018